Sands Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $143M | Sell |
3,943,485
-220,076
| -5% | -$8M | 0.41% | 42 |
|
|
2025
Q1 | $151M | Sell |
4,163,561
-134,442
| -3% | -$4.87M | 0.51% | 39 |
|
|
2024
Q4 | $181M | Sell |
4,298,003
-820,252
| -16% | -$34.5M | 0.54% | 39 |
|
|
2024
Q3 | $284M | Sell |
5,118,255
-236,495
| -4% | -$13.1M | 0.86% | 34 |
|
|
2024
Q2 | $220M | Buy |
5,354,750
+1,495,303
| +39% | +$61.5M | 0.65% | 37 |
|
|
2024
Q1 | $180M | Sell |
3,859,447
-258,561
| -6% | -$12.1M | 0.5% | 41 |
|
|
2023
Q4 | $197M | Buy |
4,118,008
+1,540,791
| +60% | +$73.7M | 0.6% | 40 |
|
|
2023
Q3 | $91.9M | Sell |
2,577,217
-96,421
| -4% | -$3.44M | 0.31% | 46 |
|
|
2023
Q2 | $123M | Buy |
+2,673,638
| New | +$123M | 0.38% | 46 |
|